If you’re curious what this drug is all about and if it’s even safe to take for anxiety, you’re not alone. That’s why I ...
The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...
7d
Clinical Trials Arena on MSNCassava ends simufilam Alzheimer’s programme after second Phase III failureWhile Cassava is stopping investigations into simufilam in Alzheimer’s disease, the therapy is now being evaluated in ...
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...
Second, the dose required to reduce pain in the periphery tends to be high enough for the drug to make its way into the central nervous system. In humans, this can cause unwanted changes in mood, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results